The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3,5,7-trihydroxy-3-(4-methoxybenzyl)chroman-4-one ID: ALA4528720
PubChem CID: 12309804
Max Phase: Preclinical
Molecular Formula: C17H16O6
Molecular Weight: 316.31
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(CC2(O)COc3cc(O)cc(O)c3C2=O)cc1
Standard InChI: InChI=1S/C17H16O6/c1-22-12-4-2-10(3-5-12)8-17(21)9-23-14-7-11(18)6-13(19)15(14)16(17)20/h2-7,18-19,21H,8-9H2,1H3
Standard InChI Key: BLSFQQNRFOVLGQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
4.4023 -18.5106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4012 -19.3301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1092 -19.7391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1074 -18.1017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8161 -18.5070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8149 -19.3276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5211 -19.7367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2330 -19.3296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2341 -18.5090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5234 -18.0954 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6945 -18.1022 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5188 -20.5539 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9395 -19.7402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6484 -19.3336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3522 -19.7478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0605 -19.3419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0632 -18.5238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3517 -18.1134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6462 -18.5217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7715 -18.1163 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1109 -20.5563 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7727 -17.2991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2268 -20.1450 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
1 11 1 0
7 12 2 0
8 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
3 21 1 0
20 22 1 0
8 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: YesOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 316.31Molecular Weight (Monoisotopic): 316.0947AlogP: 1.66#Rotatable Bonds: 3Polar Surface Area: 96.22Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.76CX Basic pKa: ┄CX LogP: 2.57CX LogD: 2.41Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.80Np Likeness Score: 1.67
References 1. Schwikkard S, Whitmore H, Sishtla K, Sulaiman RS, Shetty T, Basavarajappa HD, Waller C, Alqahtani A, Frankemoelle L, Chapman A, Crouch N, Wetschnig W, Knirsch W, Andriantiana J, Mas-Claret E, Langat MK, Mulholland D, Corson TW.. (2019) The Antiangiogenic Activity of Naturally Occurring and Synthetic Homoisoflavonoids from the Hyacinthaceae ( sensu APGII)., 82 (5): [PMID:30951308 ] [10.1021/acs.jnatprod.8b00989 ] 2. Kishore N, Kumar P, Shanker K, Verma AK.. (2019) Human disorders associated with inflammation and the evolving role of natural products to overcome., 179 [PMID:31255927 ] [10.1016/j.ejmech.2019.06.034 ]